thumbnail

Limited infection upon human exposure to a recombinant raccoon pox vaccine vector

Vaccine

By:
ORCID iD , , , , , and
https://doi.org/10.1016/j.vaccine.2004.01.030

Links

Abstract

A laboratory accident resulted in human exposure to a recombinant raccoon poxvirus (RCN) developed as a vaccine vector for antigens of Yersinia pestis for protection of wild rodents (and other animals) against plague. Within 9 days, the patient developed a small blister that healed within 4 weeks. Raccoon poxvirus was cultured from the lesion, and the patient developed antibody to plague antigen (F1) and RCN. This is the first documented case of human exposure to RCN.

Additional publication details

Publication type:
Article
Publication Subtype:
Journal Article
Title:
Limited infection upon human exposure to a recombinant raccoon pox vaccine vector
Series title:
Vaccine
DOI:
10.1016/j.vaccine.2004.01.030
Volume:
22
Issue:
21-22
Year Published:
2004
Language:
English
Publisher:
Elsevier
Contributing office(s):
National Wildlife Health Center
Description:
4 p.
First page:
2757
Last page:
2760